• Overview
  Quotes Prices Key Stats News Press Releases Sentiment
• Charts
  Chart Technicals
• Company
  Splits Dividends Recommendations Price Target Insider Trades Holders Peers Filings Notes due Fail to deliver ESG Score Executive Compensation Profile
• Earnings
  Price Reaction Earnings Estimates Trends Call Transcripts
• Financials
  Fundamentals Rating DCF Beta
• Analysis
  Up/Down Intra-day Events Performance Recovery Returns Price Distribution Unusual Volume Best Days Data Correlations Seasonality Volatility Trader Stats

Charts

InteractiveQuickClassicGallery

View

Analyze

2.00 0.03(1.52%)11/19/2024
Inhibikase Therapeutics Inc (IKT)

Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1